You have reached the HIVandHepatitis.com legacy site. Please visit our new site at hivandhepatitis.com

 Google Custom Search
HIV-HBV Coinfection Top News Articles
Kidney Function in HIV/HBV Coinfected Patients on Tenofovir
April 19, 2011
Hepatitis B Treatment Improves Liver Disease in HIV/HBV Coinfected
March 29, 2011
Liver Fibrosis Raises Risk of Kidney Impairment in HIV/HBV Coinfected Patients on Tenofovir
March 18, 2011
More Liver-related Death for HIV/HBV than HIV/HCV Coinfection in MACS Cohort
March 11, 2011
Tenofovir Remains Effective against Hepatitis B Virus after 5 Years in HIV/HBV Coinfected Patients
February 25, 2011
Tenofovir Remains Effective against Hepatitis B Virus after 5 Years in HIV/HBV Coinfected Patients
February 18, 2011
U.S. Antiretroviral Therapy Guidelines Updated, but No Major Changes
January 14, 2011
Kidney Impairment on Tenofovir More Likely in HIV/HBV Coinfected Patients with Advanced Fibrosis
November 11, 2010
Drug Resistance Linked to Faster Hepatitis B Liver Disease Progression in HIV/HBV Coinfected Patients
August 17, 2010
Higher CD4 Cell Count Linked to Hepatitis B Surface Antigen Loss in HIV/HBV Coinfected Patients
April 16, 2010
HIV/HBV Coinfected People at High Risk for Disease Progression During Antiretroviral Treatment Interruption
March 9, 2010
HIV/HBV and HIV/HCV Coinfected People with Impaired Liver Function and Inflammation Have Higher Risk of Non-AIDS Death
March 9, 2010
Poor Response to Hepatitis B Vaccine Predicts HIV Disease Progression
March 9, 2010
HIV/HBV and HIV/HCV Coinfected Patients in Africa Have Slower CD4 Recovery on Antiretroviral Therapy, but Not Increased Mortality
March 6, 2010
Liver Toxicity in an International Cohort of HIV/HBV Coinfected Patients on Long-term Antiretroviral Therapy
March 2, 2010
Epidemiology of HIV/HBV Coinfection in a U.S. Military Cohort
January 19, 2010
HIV/HBV Coinfected Patients with Elevated ALT and AST Are at Greater Risk for Liver Disease Progression
January 19, 2010
Tenofovir (Viread) Suppresses HBV Viral Load Long-term in HIV/HBV Coinfected Patients, but Kidney Function May Decline
November 3, 2009
T-cell Response against Hepatitis B Virus Is Impaired in HIV-HBV Coinfected Individuals
September 25, 2009
HIV-HBV Coinfected Patients Respond to Antiretroviral Therapy as well as HIV Monoinfected, but Have a Higher Risk of Non-AIDS Death
September 25, 2009
HIV Coinfection Has Little Effect on Response to Chronic Hepatitis B Treatment
June 16, 2009
Patients Coinfected with HIV and Hepatitis B Virus Can Undergo Liver Transplantation with Excellent Results
June 16, 2009
Mechanisms of Accelerated Fibrosis in HIV-HCV and HIV-HBV Coinfected Individuals
May 15, 2009
Laboratory Study Shows Hepatitis B Drug Entecavir (Baraclude) -- But Not Telbivudine (Tyzeka) -- Has Activity against Multiple Strains of HIV
May 15, 2009
Combination Antiretroviral Therapy is Well-tolerated and Rapidly Suppresses HBV Viral Load in HIV-HBV Coinfected Patients
May 15, 2009
Occult Hepatitis B Virus in HIV Patients with Low CD4 Cell Counts May Resolve after Starting Antiretroviral Therapy
April 21, 2009
Liver Disease Is a Growing Cause of Death for HIV Positive People in France, but Has Leveled Off in Spain
April 7, 2009

ImQuest Identifies First Non-nucleoside Inhibitors of Hepatitis B Virus
April 7, 2009

Effect of HIV Immunosuppression on Response to Hepatitis B and HBV Evolution
April 3, 2009
Outcomes of Liver Transplantation in HIV Positive Recipients Coinfected with Hepatitis B or C
March 20, 2009
ALT Flares in HIV-HBV Coinfected Patients after Starting Antiretroviral Therapy
March 20, 2009
Studies Look at Liver Fibrosis in HIV-HCV and HIV-HBV Coinfected
People
March 13, 2009
Treatment of HIV-HBV Coinfected Patients in South Africa
January 10, 2009
SMART Study Shows Antiretroviral Treatment Interruption Is Particularly Risky for Patients with HIV-HBV or HIV-HCV Coinfection
December 15, 2008
Baseline CD4 Cell Count Predicts HBV DNA Decline in HIV Negative and HIV Positive Patients Treated with Adefovir (Hepsera)
December 15, 2008
Management of HIV Positive Patients with Chronic Hepatitis B Who Are Not Eligible for Antiretroviral Therapy
December 15, 2008
Tenofovir (Viread) for Patients with HIV-HBV Coinfection
November 15, 2008
HAART Improves Hepatitis B Vaccine Response Regardless of CD4 Count
November 15, 2008
Liver Enzyme Elevations in HIV Positive Individuals with Occult Hepatitis B Virus Infection
October 15, 2008
Thai Study Confirms Efficacy of Tenofovir (Viread) Regimens for HIV-HBV Coinfected Patients
October 15, 2008
Laboratory Study Provides Details on Entecavir (Baraclude) Activity against Various Types of HIV
August 29, 2008
HIV Positive Individuals Are at Higher Risk of Occult Hepatitis B Virus Infection, but Occult Hepatitis C Virus Is Rare
August 29, 2008
Predictors of Hepatitis B Surface Antigen Loss in HIV-HBV Coinfected Individuals
August 29, 2008
Updated Recommendations for Management of HIV Positive Patients with Chronic Hepatitis B Virus Coinfection
July 15, 2008
Multicenter Evaluation Sheds Further Light on Anti-HIV Activity of Entecavir (Baraclude)
June 20, 2008
Influence of Occult Hepatitis B Virus on Liver Disease Progression and Response to Interferon-based Therapy in HIV-HCV Coinfected Patients
June 2, 2008
FDA Proposes New Rule to Provide Updated Information on Use of Prescription Drugs and Biological Products during Pregnancy and Breast-feeding
June 2, 2008
Risk of Using Entecavir (Baraclude) without Concomitant Antiretroviral Therapy in HIV-HBV Coinfected Patients
May 15, 2008
Hepatitis B Coinfection Does Not Interfere with Response to Antiretroviral Therapy
April 11, 2008
Another Report of Drug-resistant HIV in a Patient Treated with Entecavir (Baraclude) for Hepatitis B
April 11, 2008

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


Reports on Most Recent
Coinfection-related
Research Conferences


Noimage

Noimage
Assessing Best Practices in
HBV Therapy
2010 CME/CE Talking Slides Update

Noimage

Noimage

Noimage

FDA-approved HIV and AIDS Treatments

Protease Inhibitors
non Nucleoside Reverse
  
Transcriptase Inhibitors

Nucleoside / Nucleotide
  
Reverse Transcriptase Inhibitors

Fixed-dose Combinations
Entry / Fusion Inhibitors
Integrase Inhibitors
Treatment Guidelines
Experimental Treatments
FDA-approved HIV
and AIDS Treatments
Pegasys + Copegus
PEG-Intron + Rebetol
Intron A + Rebetol
Roferon A + Ribavirin
Treatment Guidelines
Experimental Treatments
 
FDA-approved Combination Therapies for Chronic HBV Infection
Baraclude  (entecavir)
Epivir-HBV   (lamivudine; 3TC)
Intron A   (interferon alfa-2b)

Hepsera   (adefovir dipivoxil)
Pegasys  (peginterferon alfa-2a)
Tyzeka    (telbivudine)